Revenue: $4.2 million for Q1 2025, a 37% increase from $3.1 million in Q1 2024. Product Revenue: $2.9 million, including $5,000 from related parties. Service Revenue: $1.2 million, including $47,000 ...
Fourth Quarter Revenue: $4 million, a decrease of 10% from $4.4 million in Q4 2023. Full Year Revenue: $14.2 million, a decrease of 15% from $16.7 million in 2023. Gross Margin (Q4 2024): 51%, up from ...
Good day, and thank you for standing by. Welcome to the Seer, Inc. Third Quarter 2024 Earnings Conference Call [Operator Instructions]. Please be advised that today's conference is being recorded. I ...
Seer, Inc. reported its financial results for the first quarter of 2025, highlighting a revenue of $4.2 million, a 37% increase from the same period last year, driven by higher product and service ...
Seer and Korea University launch a study to identify blood-based cancer biomarkers using advanced mass spectrometry and AI analytics. Seer, Inc. and Korea University have launched a groundbreaking ...
Good day and thank you for standing by. Welcome to the Seer Fourth Quarter and Full-Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results